UnicoCell Biomed Co., Ltd. (TPE:6794)
Taiwan · Delayed Price · Currency is TWD 67.40
-0.70 (-1.03%)
Aug 19, 2026, 1:21 PM CST
UnicoCell Biomed Market Cap
UnicoCell Biomed has a market cap or net worth of 4.33 billion as of August 18, 2026. Its market cap has decreased by -6.76% in one year.
Market Cap
4.33B
Enterprise Value
3.68B
Revenue
22.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.40
ChartMarket Cap Chart
Since December 25, 2020, UnicoCell Biomed's market cap has increased from 1.73B to 4.33B, an increase of 150.80%. That is a compound annual growth rate of 17.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 4.33B | -20.29% |
| Dec 31, 2025 | 5.44B | 36.28% |
| Dec 31, 2024 | 3.99B | -13.33% |
| Dec 29, 2023 | 4.60B | 239.58% |
| Dec 30, 2022 | 1.36B | -17.13% |
| Dec 30, 2021 | 1.64B | 1.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sinphar Pharmaceutical | 6.02B |
| TWi Biotechnology | 5.54B |
| Steminent Biotherapeutics | 5.18B |
| AnnJi Pharmaceutical | 5.16B |
| Mycenax Biotech | 5.06B |
| Medigen Biotechnology | 4.70B |
| Pharmosa Biopharm | 4.27B |
| Sinew Pharma | 4.11B |